Breaking News

Ampersand to Acquire Vibalogics

CDMO will expand capabilities to meet growing demand for development and manufacturing of complex viral products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Vibalogics GmbH, a contract development and manufacturing organization (CDMO) focused on complex live biological products, is being acquired by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the healthcare sector. Ampersand’s growth investment will be used to expand Vibalogics’ capabilities to meet growing industry demand for the development and manufacturing of complex viral products.   Vibalogics offers process development, manufacturing and fill...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters